Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ufp Technologies (UFPT) Dividends Paid - Common (2011 - 2012)

Ufp Technologies posted quarterly Dividends Paid - Common of -$223.0 for Q4 2012, down 127.29% year-on-year from $817.0 in Q1 2012, and up 98.35% on a QoQ basis from -$13509.0 in Q3 2012.

Ufp Technologies (UFPT) has 2 years of Dividends Paid - Common data on file, last reported at -$223.0 in Q4 2012.

  • For the quarter ending Q4 2012, Dividends Paid - Common fell 127.29% year-over-year to -$223.0; the trailing twelve-month figure through Dec 2012 stood at $1.2 million (up 312.41% YoY), and the FY2012 full-year result was $1.2 million, up 312.41% from the prior year.
  • Dividends Paid - Common for Q4 2012 stood at -$223.0, up from -$13509.0 in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $1.2 million in Q1 2012 and bottomed at -$13509.0 in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.10 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 337.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 911.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 61.80 Mn
10 Ufp Technologies 1.69 Bn 1.67 Bn 44.36 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 -223.00
Dec 31, 2012 -223.00
Sep 30, 2012 -13,509.00
Sep 30, 2012 -13,509.00
Mar 31, 2012 1.21 Mn
Mar 31, 2012 1.21 Mn
Dec 31, 2011 817.00
Dec 31, 2011 817.00
Jun 30, 2011 184,183.00
Jun 30, 2011 184,183.00
Mar 31, 2011 105,000.00
Mar 31, 2011 105,000.00